NCT01244607View on ClinicalTrials.gov

NI-0801 in Allergic Contact Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

Not specified

Conditions
Allergic Contact Dermatitis
Interventions
DRUG

Placebo

single i.v. administration

DRUG

NI-0801

single i.v. administration

Sponsors
All Listed Sponsors
lead

Light Chain Bioscience - Novimmune SA

INDUSTRY